“Last year Bristol Myers Squibb teamed up with GRYT Health to create a virtual conference and information hub geared toward connecting patients and advocates with industry leaders, clinicians and other health experts. In 2021, the COVID Advocacy Exchange will create formal working groups to address ongoing needs identified by the Exchange’s growing number of users.
The spread of COVID-19 across the globe in early spring 2020 – and the resulting cancellation of in-person meetings and conferences – stifled the connection between biopharma companies and the global advocacy community. While some meetings pivoted to virtual gatherings, others were cancelled. This disconnected patients and advocacy organizations from information and resources they needed to cope with pandemic-related challenges.”